Veeva Systems Dossier
Qualitative Analysis
Business overview
Veeva Systems Inc. is the leading provider of industry cloud solutions for the global life sciences industry. The company's offerings span cloud software, data, and business consulting, designed to meet the unique needs of strategic business functions from research and development (R&D) through commercialization. Veeva operates primarily through two major product suites: Veeva Development Cloud (which includes application suites for clinical, regulatory, and safety functions built on the unified Veeva Vault platform) and Veeva Commercial Cloud (which includes Vault CRM, commercial content, and data solutions). As a Public Benefit Corporation, Veeva is legally mandated to balance the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.
Research as of 29 Jul 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Veeva is extending its industry cloud from applications into applications plus AI agents. Vault AI expanded across applications in August 2026, while Falcon is being developed as an agentic-labor platform for clinical, regulatory, safety, and MLR workflows.
Veeva is migrating life-sciences customers from legacy Veeva CRM to Vault CRM and layering in agents such as Agentic Call Report. By August 2026, more than 180 customers were live and 12 top-20 biopharmas had committed globally.
Veeva is broadening connected clinical, safety, quality, manufacturing, and research-site workflows. Initiatives include eSource for straight-through site-to-sponsor clinical data, EHS for unified risk workflows, and continuing adoption of EDC, Safety, QMS, QualityDocs, and Training.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Ostro adds a life-sciences brand-engagement platform that provides patients and healthcare professionals compliant, AI-driven answers and engagement insights, extending Veeva's Agentic Commercial capabilities.
Copli adds agentic medical, legal, and regulatory review technology intended to automate compliance checks and shorten life-sciences content-review cycles.
Strategic Partnerships
The agreement expands BioMarin's use of, and strategic input into, Veeva software, data, services, and consulting across therapy development and commercialization.